Biotransformation of ent-kaur-16-en-19-oic acid by Absidia blakesleeana and Rhizopus oligosporus.
Biotransformation of ent-kaur-16-en-19-oic acid was carried out with Absidia blakesleeana and Rhizopus oligosporus. Absidia blakesleeana produced two novel metabolites, ent-(7alpha, 9alpha)-dihydroxy-kaur-16-en-19-oic acid and ent-(1beta, 7alpha)-dihydroxy-kaur-16-en-19-oic acid, together with three known compounds: ent-7alpha-hydroxy-kaur-16-en-19-oic acid, ent-(7alpha, 11beta)-dihydroxy-kaur-16-en-19-oic acid and ent-(7alpha, 13)-dihydroxy-kaur-16-en-19-oic acid. The ent-7alpha-hydroxy-kaur-16-en-19-oic acid and ent-(7alpha, 9alpha)-dihydroxy-kaur-16-en-19-oic acid were obtained from R. oligosporus. The structures were established by spectroscopic techniques and X-ray crystallography.